Creative Planning
TNDM icon

Creative Planning’s Tandem Diabetes Care TNDM Stock Holding History

Creative Planning’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$3K – 2536
2022
Q1 		$3K Buy
+100
New +$11.7K ﹤0.01% 2287
2020
Q1 		– Sell
-3,000
Closed -$11K – 2076
2019
Q4 		$11K Buy
+3,000
New +$185K ﹤0.01% 1905

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Creative Planning's TNDM Position: Q1 2026 in Review

Creative Planning sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 9,478 shares — an estimated $208K sold.

Creative Planning first reported a position in TNDM in Q3 2015 and held it in 28 quarters. The position peaked at $1.23M in Q2 2019. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Creative Planning reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • Creative Planning sold 9,478 Tandem Diabetes Care shares in Q1 2026, an estimated $208K.
  • Creative Planning first reported a position in Tandem Diabetes Care in Q3 2015 and held it in 28 quarters.
  • Creative Planning's Tandem Diabetes Care position peaked at $1.23M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.